Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage

Current — Gland Pharma Limited

The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Gland Pharma Limited with status Current. The shortage was first posted on Apr 10, 2020.

Shortage details

Status
Current
Company
Gland Pharma Limited
Package NDC
66794-230-42
Dosage Form
Injection
Presentation
Dexmedetomidine Hydrochloride, Injection, 200 ug/2 mL (NDC 66794-230-42)
Initial Posting
Apr 10, 2020

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.